3.22.1 html 157 349 1 false 70 0 false 5 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - Consolidated Balance Sheets Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 100020 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 100030 - Statement - Consolidated Statements of Operations and Comprehensive Loss Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 100040 - Statement - Consolidated Statements of Convertible Preferred Units and Stockholders' Equity/ Members' (Deficit) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredUnitsAndStockholdersEquityMembersDeficit Consolidated Statements of Convertible Preferred Units and Stockholders' Equity/ Members' (Deficit) Statements 5 false false R6.htm 100050 - Statement - Consolidated Statements of Convertible Preferred Units and Stockholders' Equity/ Members' (Deficit) (Parenthetical) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfConvertiblePreferredUnitsAndStockholdersEquityMembersDeficitParenthetical Consolidated Statements of Convertible Preferred Units and Stockholders' Equity/ Members' (Deficit) (Parenthetical) Statements 6 false false R7.htm 100060 - Statement - Consolidated Statements of Cash Flows Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 7 false false R8.htm 100070 - Disclosure - Organization and Description of Business Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusiness Organization and Description of Business Notes 8 false false R9.htm 100080 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 100090 - Disclosure - Fair Value Measurements Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureFairValueMeasurements Fair Value Measurements Notes 10 false false R11.htm 100100 - Disclosure - Collaboration Revenue Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureCollaborationRevenue Collaboration Revenue Notes 11 false false R12.htm 100110 - Disclosure - Balance Sheet Components Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureBalanceSheetComponents Balance Sheet Components Notes 12 false false R13.htm 100120 - Disclosure - Commitments and Contingencies Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 13 false false R14.htm 100130 - Disclosure - Debt Obligation Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureDebtObligation Debt Obligation Notes 14 false false R15.htm 100140 - Disclosure - Convertible Preferred Units and Stockholders' Equity/Members' Deficit Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureConvertiblePreferredUnitsAndStockholdersEquityMembersDeficit Convertible Preferred Units and Stockholders' Equity/Members' Deficit Notes 15 false false R16.htm 100150 - Disclosure - Warrants Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureWarrants Warrants Notes 16 false false R17.htm 100160 - Disclosure - Share-Based Compensation Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureShareBasedCompensation Share-Based Compensation Notes 17 false false R18.htm 100170 - Disclosure - Employee Benefit Plan Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlan Employee Benefit Plan Notes 18 false false R19.htm 100180 - Disclosure - Income Taxes Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureIncomeTaxes Income Taxes Notes 19 false false R20.htm 100190 - Disclosure - Net Loss Per Share Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureNetLossPerShare Net Loss Per Share Notes 20 false false R21.htm 100200 - Disclosure - Related Party Transactions Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureRelatedPartyTransactions Related Party Transactions Notes 21 false false R22.htm 100210 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies 22 false false R23.htm 100220 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies 23 false false R24.htm 100230 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureFairValueMeasurements 24 false false R25.htm 100240 - Disclosure - Balance Sheet Components (Tables) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsTables Balance Sheet Components (Tables) Tables http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureBalanceSheetComponents 25 false false R26.htm 100250 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingencies 26 false false R27.htm 100260 - Disclosure - Debt Obligation (Tables) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureDebtObligationTables Debt Obligation (Tables) Tables http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureDebtObligation 27 false false R28.htm 100270 - Disclosure - Convertible Preferred Units and Stockholders' Equity/Members' Deficit (Tables) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureConvertiblePreferredUnitsAndStockholdersEquityMembersDeficitTables Convertible Preferred Units and Stockholders' Equity/Members' Deficit (Tables) Tables http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureConvertiblePreferredUnitsAndStockholdersEquityMembersDeficit 28 false false R29.htm 100280 - Disclosure - Share-Based Compensation (Tables) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureShareBasedCompensationTables Share-Based Compensation (Tables) Tables http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureShareBasedCompensation 29 false false R30.htm 100290 - Disclosure - Income Taxes (Tables) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables Income Taxes (Tables) Tables http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureIncomeTaxes 30 false false R31.htm 100300 - Disclosure - Net Loss Per Share (Tables) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureNetLossPerShareTables Net Loss Per Share (Tables) Tables http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureNetLossPerShare 31 false false R32.htm 100310 - Disclosure - Organization and Description of Business - Additional Information (Details) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureOrganizationAndDescriptionOfBusinessAdditionalInformationDetails Organization and Description of Business - Additional Information (Details) Details 32 false false R33.htm 100320 - Disclosure - Summary of Significant Accounting Policies - Summary of Reconciliation of Cash and Cash Equivalents and Restricted Cash (Details) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfReconciliationOfCashAndCashEquivalentsAndRestrictedCashDetails Summary of Significant Accounting Policies - Summary of Reconciliation of Cash and Cash Equivalents and Restricted Cash (Details) Details 33 false false R34.htm 100330 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails Summary of Significant Accounting Policies - Additional Information (Details) Details 34 false false R35.htm 100340 - Disclosure - Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis by Level Within Fair Value Hierarchy (Details) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisByLevelWithinFairValueHierarchyDetails Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis by Level Within Fair Value Hierarchy (Details) Details 35 false false R36.htm 100350 - Disclosure - Fair Value Measurements - Schedule of Fair Value and Amortized Cost of Investments in Marketable Securities (Details) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFairValueAndAmortizedCostOfInvestmentsInMarketableSecuritiesDetails Fair Value Measurements - Schedule of Fair Value and Amortized Cost of Investments in Marketable Securities (Details) Details 36 false false R37.htm 100360 - Disclosure - Fair Value Measurements - Schedule of Fair Value of Marketable Securities by Maturity Date (Details) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFairValueOfMarketableSecuritiesByMaturityDateDetails Fair Value Measurements - Schedule of Fair Value of Marketable Securities by Maturity Date (Details) Details 37 false false R38.htm 100370 - Disclosure - Fair Value Measurements - Changes In Fair Values of Convertible Preferred Stock Warrants and Common Stock Warrants, Classified as Level 3 Financial Liabilities (Details) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureFairValueMeasurementsChangesInFairValuesOfConvertiblePreferredStockWarrantsAndCommonStockWarrantsClassifiedAsLevel3FinancialLiabilitiesDetails Fair Value Measurements - Changes In Fair Values of Convertible Preferred Stock Warrants and Common Stock Warrants, Classified as Level 3 Financial Liabilities (Details) Details 38 false false R39.htm 100380 - Disclosure - Collaboration Revenue - Additional Information (Details) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureCollaborationRevenueAdditionalInformationDetails Collaboration Revenue - Additional Information (Details) Details 39 false false R40.htm 100390 - Disclosure - Balance Sheet Components - Schedule of Property and Equipment, Net (Details) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetails Balance Sheet Components - Schedule of Property and Equipment, Net (Details) Details 40 false false R41.htm 100400 - Disclosure - Balance Sheet Components - Additional Information (Details) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetails Balance Sheet Components - Additional Information (Details) Details 41 false false R42.htm 100410 - Disclosure - Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails Balance Sheet Components - Schedule of Accrued Expenses and Other Current Liabilities (Details) Details 42 false false R43.htm 100420 - Disclosure - Commitments and Contingencies - Additional Information (Details) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails Commitments and Contingencies - Additional Information (Details) Details 43 false false R44.htm 100430 - Disclosure - Commitments and Contingencies - Schedule of Minimum Future Rental Payments Owned Under Operating lease (Details) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfMinimumFutureRentalPaymentsOwnedUnderOperatingLeaseDetails Commitments and Contingencies - Schedule of Minimum Future Rental Payments Owned Under Operating lease (Details) Details 44 false false R45.htm 100440 - Disclosure - Debt Obligation - Additional Information (Details) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureDebtObligationAdditionalInformationDetails Debt Obligation - Additional Information (Details) Details 45 false false R46.htm 100450 - Disclosure - Debt Obligation - Schedule of Future Debt Payments (Details) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureDebtObligationScheduleOfFutureDebtPaymentsDetails Debt Obligation - Schedule of Future Debt Payments (Details) Details 46 false false R47.htm 100460 - Disclosure - Convertible Preferred Units and Stockholders' Equity/Members' Deficit - Summary of Authorized, Issued and Outstanding Convertible Preferred Units (Details) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureConvertiblePreferredUnitsAndStockholdersEquityMembersDeficitSummaryOfAuthorizedIssuedAndOutstandingConvertiblePreferredUnitsDetails Convertible Preferred Units and Stockholders' Equity/Members' Deficit - Summary of Authorized, Issued and Outstanding Convertible Preferred Units (Details) Details 47 false false R48.htm 100470 - Disclosure - Convertible Preferred Units and Stockholders' Equity/Members' Deficit - Additional Information (Details) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureConvertiblePreferredUnitsAndStockholdersEquityMembersDeficitAdditionalInformationDetails Convertible Preferred Units and Stockholders' Equity/Members' Deficit - Additional Information (Details) Details 48 false false R49.htm 100480 - Disclosure - Warrants - Additional Information (Details) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureWarrantsAdditionalInformationDetails Warrants - Additional Information (Details) Details 49 false false R50.htm 100490 - Disclosure - Share-Based Compensation - Additional Information (Details) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureShareBasedCompensationAdditionalInformationDetails Share-Based Compensation - Additional Information (Details) Details 50 false false R51.htm 100500 - Disclosure - Share-Based Compensation - Summary of PI Units Activity (Details) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfPIUnitsActivityDetails Share-Based Compensation - Summary of PI Units Activity (Details) Details 51 false false R52.htm 100510 - Disclosure - Share-Based Compensation - Summary of Unvested Common Stock Activity (Details) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfUnvestedCommonStockActivityDetails Share-Based Compensation - Summary of Unvested Common Stock Activity (Details) Details 52 false false R53.htm 100520 - Disclosure - Share-Based Compensation - Summary of Estimated Grant-Date Fair Value of Units/Awards Calculated Using Black-Scholes Option Pricing Model (Details) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfEstimatedGrantDateFairValueOfUnitsAwardsCalculatedUsingBlackScholesOptionPricingModelDetails Share-Based Compensation - Summary of Estimated Grant-Date Fair Value of Units/Awards Calculated Using Black-Scholes Option Pricing Model (Details) Details 53 false false R54.htm 100530 - Disclosure - Share-Based Compensation - Summary of Stock Option Activity under 2021 Plan (Details) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfStockOptionActivityUnder2021PlanDetails Share-Based Compensation - Summary of Stock Option Activity under 2021 Plan (Details) Details 54 false false R55.htm 100540 - Disclosure - Share-Based Compensation - Summary of Recognized Share-Based Compensation (Details) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureShareBasedCompensationSummaryOfRecognizedShareBasedCompensationDetails Share-Based Compensation - Summary of Recognized Share-Based Compensation (Details) Details 55 false false R56.htm 100550 - Disclosure - Employee Benefit Plan - Additional Information (Details) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureEmployeeBenefitPlanAdditionalInformationDetails Employee Benefit Plan - Additional Information (Details) Details 56 false false R57.htm 100560 - Disclosure - Income Taxes - Summary of Reconciliation of Effective Income Tax Rate (Detail) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfEffectiveIncomeTaxRateDetail Income Taxes - Summary of Reconciliation of Effective Income Tax Rate (Detail) Details 57 false false R58.htm 100570 - Disclosure - Income Taxes - Schedule of Components of Deferred Tax Assets and Liabilities (Detail) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfComponentsOfDeferredTaxAssetsAndLiabilitiesDetail Income Taxes - Schedule of Components of Deferred Tax Assets and Liabilities (Detail) Details 58 false false R59.htm 100580 - Disclosure - Income Taxes - Additional Information (Detail) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail Income Taxes - Additional Information (Detail) Details 59 false false R60.htm 100590 - Disclosure - Income Taxes - Schedule of Pre-Tax Net Operating Losses and Credit Carryforwards (Detail) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfPreTaxNetOperatingLossesAndCreditCarryforwardsDetail Income Taxes - Schedule of Pre-Tax Net Operating Losses and Credit Carryforwards (Detail) Details 60 false false R61.htm 100600 - Disclosure - Income Taxes - Schedule of Reconciliation of Unrecognized Tax Benefits (Detail) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfUnrecognizedTaxBenefitsDetail Income Taxes - Schedule of Reconciliation of Unrecognized Tax Benefits (Detail) Details 61 false false R62.htm 100610 - Disclosure - Net Loss Per Share - Summary of Outstanding Shares Have Been Excluded from Computation of Diluted Net Loss Per Share Because Their Effect Would have Been Anti-Dilutive (Details) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureNetLossPerShareSummaryOfOutstandingSharesHaveBeenExcludedFromComputationOfDilutedNetLossPerShareBecauseTheirEffectWouldHaveBeenAntiDilutiveDetails Net Loss Per Share - Summary of Outstanding Shares Have Been Excluded from Computation of Diluted Net Loss Per Share Because Their Effect Would have Been Anti-Dilutive (Details) Details 62 false false R63.htm 100620 - Disclosure - Related Party Transactions (Details) Sheet http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureRelatedPartyTransactionsDetails Related Party Transactions (Details) Details http://www.dicetherapeutics.com/20211231/taxonomy/role/DisclosureRelatedPartyTransactions 63 false false All Reports Book All Reports dice-10k_20211231.htm dice-20211231.xsd dice-20211231_cal.xml dice-20211231_def.xml dice-20211231_lab.xml dice-20211231_pre.xml dice-ex211_658.htm dice-ex231_657.htm dice-ex311_662.htm dice-ex312_661.htm dice-ex321_659.htm dice-ex322_660.htm dice-ex43_652.htm gtlhm4pf4hlt000001.jpg gtlhm4pf4hlt000002.jpg gtlhm4pf4hlt000003.jpg gtlhm4pf4hlt000004.jpg gtlhm4pf4hlt000005.jpg gtlhm4pf4hlt000006.jpg gtlhm4pf4hlt000007.jpg gtlhm4pf4hlt000008.jpg gtlhm4pf4hlt000009.jpg gtlhm4pf4hlt000010.jpg gtlhm4pf4hlt000011.jpg gtlhm4pf4hlt000012.jpg gtlhm4pf4hlt000013.jpg gtlhm4pf4hlt000014.jpg gtlhm4pf4hlt000015.jpg gtlhm4pf4hlt000016.jpg gtlhm4pf4hlt000017.jpg gtlhm4pf4hlt000018.jpg http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021q4 true true